Studies have further characterized that TILs consisting of an increased CD8+/CD4+ T cell ratio and of natural killer (NK) cells correlated with patient survival and therapy response in breast cancer [15–18], suggesting that cytotoxic immunity favors tumor destruction. The gene discussed is CD4; the disease is breast carcinoma.